Revenue: As of FY2025 Q3, the actual value is USD 1.694 M.EPS: As of FY2025 Q3, the actual value is USD 0.04.EBIT: As of FY2025 Q3, the actual value is USD 76.22 K.<h3>Segment Revenue</h3><ul><li>Nutraceutical (supplements): Revenue for the three months ended September 30, 2025 was $1,673,268, compared to $1,367,964 for the same period in 2024. For the nine months ended September 30, 2025, revenue was $4,996,424, compared to $4,797,884 in 2024.</li><li>Hemp derived products: Revenue for the three months ended September 30, 2025 was $20,906, compared to $27,949 for the same period in 2024. For the nine months ended September 30, 2025, revenue was $120,539, compared to $88,475 in 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income/Loss: For the three months ended September 30, 2025, net income was $259,001, compared to a net loss of -$288,081 for the same period in 2024. For the nine months ended September 30, 2025, net loss was -$93,837, compared to -$281,606 in 2024.</li><li>Gross Profit: For the three months ended September 30, 2025, gross profit was $978,350, compared to $763,719 for the same period in 2024. For the nine months ended September 30, 2025, gross profit was $2,813,211, compared to $2,617,373 in 2024.</li><li>Operating Income/Loss: For the three months ended September 30, 2025, operating loss was -$78,288, compared to -$218,771 for the same period in 2024. For the nine months ended September 30, 2025, operating loss was -$265,823, compared to -$93,345 in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: For the nine months ended September 30, 2025, net cash provided by operating activities was $1,478,358, compared to net cash used of -$54,178 for the same period in 2024.</li><li>Net Cash Used in Investing Activities: For the nine months ended September 30, 2025, net cash used in investing activities was -$8,512, compared to -$1,881 for the same period in 2024.</li><li>Net Cash Used in Financing Activities: For the nine months ended September 30, 2025, net cash used in financing activities was -$676,164, compared to -$68,206 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue focusing on increasing demand from direct-to-consumer sales channels, which contributed to revenue growth.</li><li>Non-Core Business: The company completed a private placement for gross proceeds of $8,000,000, issuing Series A and Series B preferred shares to institutional investors, which will be used for general corporate purposes and to pay outstanding amounts under the APA.</li></ul><h3>Unique Metrics</h3><ul><li>Employee Retention Tax Credit (ERTC) Refund: The company received an ERTC reimbursement of $491,801 during the three months ended September 30, 2025.</li></ul>

Functional Brands | 10-Q: FY2025 Q3 Revenue: USD 1.694 M